Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
09/10/2026
JPMorgan: Cuts PepsiCo price target to $137 from $138.
Latest
1 m ago
Hong Kong Stock Movement | Dairy stocks lead gains; institutions say dairy cow destocking is expected to accelerate, and raw milk prices may be at an upward turning point.
2 m ago
BlockBeats news, October 9 Moderna will officially be added to the Nasdaq 100 Index before the U.S. stock market opens at 21:30 Beijing time tonight (October 9), replacing Warner Bros. Discovery. The adjustment was announced on October 1. From the U.S. market close on October 1 before the announcement to the latest close on October 8, MRNA's stock price rose from $188.94 to $197, accumulating a gain of about 4.27%. Moderna is an American biotechnology company that develops vaccines and drugs using mRNA technology, with research covering infectious diseases, cancer, and rare diseases. In addition to its vaccine business, the company's personalized mRNA cancer therapy in collaboration with Merck announced positive Phase 3 trial results in August, meeting the primary endpoint of recurrence-free survival in adjuvant treatment for melanoma, which was the main catalyst for the stock price. Recently, a suspected pneumonic plague incident in Russia also drew attention to vaccine stocks, and Moderna rose about 6.95% on October 5. However, as of the latest publicly available information, the pathogen in the incident has still not been confirmed by the WHO; Russia said testing of contacts found no plague, and the European Centre for Disease Prevention and Control also said there is no evidence of sustained human-to-human transmission.
8 m ago
Xinxiang Chemical Fiber (000949.SZ): The company's state-owned construction land use rights have been reclaimed, and some production lines have been suspended.
11 m ago
State-owned Assets Supervision and Administration Commission of the State Council: Changes in the positions of outside directors of 6 central enterprises
12 m ago
HKD interbank rates diverge; 1-month rate falls for eighth straight day to 2.75%, a more than six-week low.
See all latest